Literature DB >> 17259502

Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.

James S Pankow1, David K Kwan, Bruce B Duncan, Maria I Schmidt, David J Couper, Sherita Golden, Christie M Ballantyne.   

Abstract

OBJECTIVE: We compared and contrasted cardiovascular disease (CVD) risk factors, subclinical manifestations of CVD, incident coronary heart disease (CHD), and all-cause mortality by categories of impaired glucose regulation in nondiabetic individuals. RESEARCH DESIGN AND METHODS: The study included 6,888 participants aged 52-75 years who had no history of diabetes or CVD. All-cause mortality and incident CHD were ascertained over a median of 6.3 years of follow-up.
RESULTS: Agreement between fasting and postchallenge glucose impairment was poor: 3,048 subjects (44%) had neither impaired fasting glucose (IFG) nor impaired glucose tolerance (IGT), 1,690 (25%) had isolated IFG, 1,000 (14%) had isolated IGT, and 1,149 (17%) had both IFG and IGT. After adjustment for age, sex, race, and center, subjects with isolated IFG were more likely to smoke, consume alcohol, and had higher mean BMI, waist circumference, LDL cholesterol, and fasting insulin and lower HDL cholesterol than those with isolated IGT, while subjects with isolated IGT had higher mean triglycerides, systolic blood pressure, and white cell counts. Measures of subclinical CVD and rates of all-cause mortality and incident CHD were similar in isolated IFG and isolated IGT.
CONCLUSIONS: Neither isolated IFG nor isolated IGT was associated with a more adverse CVD risk profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259502     DOI: 10.2337/dc06-1457

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  33 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

2.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 3.  Arguments for and against the role of glucose variability in the development of diabetes complications.

Authors:  Eric S Kilpatrick
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Joseph Yeboah; Alain G Bertoni; David M Herrington; Wendy S Post; Gregory L Burke
Journal:  J Am Coll Cardiol       Date:  2011-07-05       Impact factor: 24.094

Review 5.  Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

Authors:  Rhonda M Cooper-DeHoff; Michael A Pacanowski; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

6.  Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes.

Authors:  Hayder A Al-Aubaidy; Herbert F Jelinek
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

7.  Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).

Authors:  F Hadaegh; D Khalili; N Fahimfar; M Tohidi; F Eskandari; F Azizi
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

8.  Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

Authors:  E Ferrannini; M Massari; M Nannipieri; A Natali; R Lopez Ridaura; C Gonzales-Villalpando
Journal:  Diabetologia       Date:  2009-02-18       Impact factor: 10.122

9.  Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study.

Authors:  Anna M Kucharska-Newton; David J Couper; James S Pankow; Ronald J Prineas; Thomas D Rea; Nona Sotoodehnia; Aravinda Chakravarti; Aaron R Folsom; David S Siscovick; Wayne D Rosamond
Journal:  Acta Diabetol       Date:  2009-10-24       Impact factor: 4.280

10.  Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects.

Authors:  Qun Yan; Wei Q Gu; Jie Hong; Yi F Zhang; Yu X Su; Ming H Gui; Yu Zhang; Zhen N Chi; Yu W Zhang; Xiao Y Li; Guang Ning
Journal:  Endocrine       Date:  2009-10-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.